WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007115376) ANTI-ANGIOGENIC AGENTS AND METHODS OF THEIR USE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/115376    International Application No.:    PCT/AU2007/000477
Publication Date: 18.10.2007 International Filing Date: 11.04.2007
IPC:
A61K 38/16 (2006.01), A61P 9/10 (2006.01), A61P 7/00 (2006.01), G01N 33/53 (2006.01)
Applicants: THE UNIVERSITY OF WESTERN AUSTRALIA [AU/AU]; Stirling Highway, Nedlands, Western Australia 6009 (AU) (For All Designated States Except US).
KBC RESEARCH FOUNDATION PRIVATE LIMITED [IN/IN]; Priya Plaza, First Floor, 127 Rajendra Prasad Road, Nehru Nagar, Chromepet (IN) (For All Designated States Except US).
ANNA UNIVERSITY [IN/IN]; Sardar Patel Road, Chennai 600025 (IN) (For All Designated States Except US).
DHARMARAJAN, Arunasalam [AU/AU]; (AU) (For US Only).
CHATTERJEE, Suvro [IN/IN]; (IN) (For US Only)
Inventors: DHARMARAJAN, Arunasalam; (AU).
CHATTERJEE, Suvro; (IN)
Agent: WRAY & ASSOCIATES; Level 4 The Quadrant, 1 William Street, Perth, Western Australia 6000 (AU)
Priority Data:
2006901898 11.04.2006 AU
Title (EN) ANTI-ANGIOGENIC AGENTS AND METHODS OF THEIR USE
(FR) AGENTS ANTI-ANGIOGÉNIQUES ET MÉTHODES POUR LES UTILISER
Abstract: front page image
(EN)The present invention relates to the use of sFRP-4 and functional variants thereof as anti-angiogenic agents. It relates to methods of treatment and screening methods using sFRP-4 and functional variants thereof. Further, it relates to compositions, and in particular pharmaceutical composition, including sFRP-4 and functional variants thereof which may be used in the various methods provided herein.
(FR)La présente invention concerne l'utilisation de sFRP-4 et de ses variantes fonctionnelles comme agents anti-angiogéniques. Elle concerne des méthodes de traitement et de criblage utilisant le sFRP-4 et ses variantes fonctionnelles. De plus, elle concerne des compositions, et en particulier une composition pharmaceutique comprenant sFRP-4 et ses variantes fonctionnelles, qui peuvent être utilisés dans plusieurs méthodes décrites dans la présente.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, MT, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)